Benign Prostatic Hyperplasia (BPH)
References
Citations
Paterson R, Goldenberg L (2001). Benign prostatic hyperplasia. In J Teichman, ed., 20 Common Problems in Urology, part 2, pp. 185–198. New York: McGraw-Hill.
Roehrborn CG, McConnell JD (2002). Etiology, pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. In PC Walsh et al., eds., Campbell's Urology, 8th ed., vol. 2, pp. 1297–1336. Philadelphia: W.B. Saunders.
Presti JC (2004). Benign prostatic hyperplasia (BPH) section of Neoplasms of the prostate gland. In EA Tanagho, JW McAninch, eds., Smith’s General Urology, 16th ed., pp. 367–374. New York: Lange Medical Books/McGraw-Hill.
AUA Practice Guidelines Committee (2003). AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. Journal of Urology, 170(2, Part 1): 530–547.
McConnell JD, et al. (2003). The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. New England Journal of Medicine, 349(25): 2387–2398.
 Go to previous section |  Go to top of page |  Go to next section |
| Author: | Douglas Dana Ralph Poore | Last Updated: August 30, 2006 |
| Medical Review: | Martin Gabica, MD - Family Medicine Adam Husney, MD - Family Medicine J. Curtis Nickel, MD, FRCSC - Urology Christopher G. Wood, MD, FACS - Urology/Oncology | |
 | ||
